Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) EPS (Basic) (2018 - 2025)

TELA Bio has reported EPS (Basic) over the past 8 years, most recently at -$0.17 for Q4 2025.

  • Quarterly results put EPS (Basic) at -$0.17 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was -$0.83 (up 37.59% YoY), and the annual figure for FY2025 was -$0.83, up 37.59%.
  • EPS (Basic) for Q4 2025 was -$0.17 at TELA Bio, up from -$0.19 in the prior quarter.
  • Over the last five years, EPS (Basic) for TELA hit a ceiling of -$0.17 in Q4 2025 and a floor of -$0.88 in Q2 2022.
  • Median EPS (Basic) over the past 5 years was -$0.5 (2022), compared with a mean of -$0.46.
  • Biggest five-year swings in EPS (Basic): crashed 54.39% in 2022 and later soared 67.92% in 2024.
  • TELA Bio's EPS (Basic) stood at -$0.59 in 2021, then rose by 18.64% to -$0.48 in 2022, then fell by 10.42% to -$0.53 in 2023, then soared by 67.92% to -$0.17 in 2024, then grew by 0.0% to -$0.17 in 2025.
  • The last three reported values for EPS (Basic) were -$0.17 (Q4 2025), -$0.19 (Q3 2025), and -$0.22 (Q2 2025) per Business Quant data.